DD238793A5 - Verfahren zur herstellung von amin-derivaten des pyrazins - Google Patents
Verfahren zur herstellung von amin-derivaten des pyrazins Download PDFInfo
- Publication number
- DD238793A5 DD238793A5 DD84259545A DD25954584A DD238793A5 DD 238793 A5 DD238793 A5 DD 238793A5 DD 84259545 A DD84259545 A DD 84259545A DD 25954584 A DD25954584 A DD 25954584A DD 238793 A5 DD238793 A5 DD 238793A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- derivatives
- pyridazine
- thienyl
- acid
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8301029A FR2539742B1 (fr) | 1983-01-24 | 1983-01-24 | Derives amines de la pyridazine substitues en position 6 par un heterocycle ou un alicycle, lesdits derives etant actifs sur le systeme nerveux central |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD238793A5 true DD238793A5 (de) | 1986-09-03 |
Family
ID=9285222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD84259545A DD238793A5 (de) | 1983-01-24 | 1984-01-23 | Verfahren zur herstellung von amin-derivaten des pyrazins |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4524070A (xx) |
| EP (1) | EP0117171B1 (xx) |
| JP (1) | JPS59139367A (xx) |
| KR (1) | KR910000641B1 (xx) |
| AT (1) | ATE28077T1 (xx) |
| AU (1) | AU560542B2 (xx) |
| CA (1) | CA1218063A (xx) |
| CS (1) | CS241539B2 (xx) |
| DD (1) | DD238793A5 (xx) |
| DE (1) | DE3464491D1 (xx) |
| DK (1) | DK31584A (xx) |
| ES (1) | ES529007A0 (xx) |
| FI (1) | FI840268A (xx) |
| FR (1) | FR2539742B1 (xx) |
| GR (1) | GR81717B (xx) |
| HU (1) | HU192390B (xx) |
| IE (1) | IE840150L (xx) |
| IL (1) | IL70757A (xx) |
| NO (1) | NO840244L (xx) |
| NZ (1) | NZ206907A (xx) |
| PT (1) | PT77982B (xx) |
| SU (1) | SU1189345A3 (xx) |
| YU (1) | YU12384A (xx) |
| ZA (1) | ZA84501B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989001508A1 (en) * | 1987-08-19 | 1989-02-23 | Martin Erich Klaus | Process for purifying and regenerating used oils |
| FR2665442B1 (fr) * | 1990-07-31 | 1992-12-04 | Sanofi Sa | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. |
| PT93060B (pt) | 1989-02-07 | 1995-12-29 | Sanofi Sa | Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem |
| US5656631A (en) * | 1989-02-07 | 1997-08-12 | Sanofi | Pyridazine derivatives |
| US5461053A (en) * | 1989-02-07 | 1995-10-24 | Sanofi | Pyridazine derivatives |
| EP1745039A4 (en) * | 2004-05-08 | 2009-07-22 | Neurogen Corp | 3-ARYL-5,6-DISUBSTITUTED PYRIDAZINES |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1292443A (en) * | 1968-11-01 | 1972-10-11 | Ct D Etudes Experimentales Et | New pyridazine derivatives and process for their preparation |
| GB1345880A (en) * | 1971-06-18 | 1974-02-06 | Cepbepe | Pyridazine derivatives |
-
1983
- 1983-01-24 FR FR8301029A patent/FR2539742B1/fr not_active Expired
-
1984
- 1984-01-18 DE DE8484400102T patent/DE3464491D1/de not_active Expired
- 1984-01-18 AT AT84400102T patent/ATE28077T1/de active
- 1984-01-18 EP EP84400102A patent/EP0117171B1/fr not_active Expired
- 1984-01-18 CA CA000445483A patent/CA1218063A/en not_active Expired
- 1984-01-18 US US06/571,698 patent/US4524070A/en not_active Expired - Fee Related
- 1984-01-19 ES ES529007A patent/ES529007A0/es active Granted
- 1984-01-20 PT PT77982A patent/PT77982B/pt not_active IP Right Cessation
- 1984-01-20 NZ NZ206907A patent/NZ206907A/en unknown
- 1984-01-23 KR KR1019840000274A patent/KR910000641B1/ko active IP Right Grant
- 1984-01-23 FI FI840268A patent/FI840268A/fi not_active Application Discontinuation
- 1984-01-23 SU SU843694357A patent/SU1189345A3/ru active
- 1984-01-23 IE IE840150A patent/IE840150L/xx unknown
- 1984-01-23 DD DD84259545A patent/DD238793A5/de unknown
- 1984-01-23 NO NO840244A patent/NO840244L/no unknown
- 1984-01-23 GR GR73585A patent/GR81717B/el unknown
- 1984-01-23 ZA ZA84501A patent/ZA84501B/xx unknown
- 1984-01-23 IL IL70757A patent/IL70757A/xx unknown
- 1984-01-24 YU YU00123/84A patent/YU12384A/xx unknown
- 1984-01-24 CS CS84530A patent/CS241539B2/cs unknown
- 1984-01-24 DK DK31584A patent/DK31584A/da unknown
- 1984-01-24 JP JP59010903A patent/JPS59139367A/ja active Pending
- 1984-01-24 AU AU23727/84A patent/AU560542B2/en not_active Ceased
- 1984-01-24 HU HU84294A patent/HU192390B/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR81717B (xx) | 1984-12-12 |
| NO840244L (no) | 1984-07-25 |
| ZA84501B (en) | 1984-09-26 |
| DK31584D0 (da) | 1984-01-24 |
| DE3464491D1 (en) | 1987-08-06 |
| FR2539742A1 (fr) | 1984-07-27 |
| EP0117171B1 (fr) | 1987-07-01 |
| PT77982B (fr) | 1986-04-10 |
| IE840150L (en) | 1984-07-24 |
| CA1218063A (en) | 1987-02-17 |
| IL70757A (en) | 1986-12-31 |
| KR840007409A (ko) | 1984-12-07 |
| YU12384A (en) | 1986-10-31 |
| KR910000641B1 (ko) | 1991-01-31 |
| JPS59139367A (ja) | 1984-08-10 |
| ES8407043A1 (es) | 1984-09-01 |
| FI840268A (fi) | 1984-07-25 |
| AU2372784A (en) | 1984-07-26 |
| CS241539B2 (en) | 1986-03-13 |
| FR2539742B1 (fr) | 1986-09-05 |
| PT77982A (fr) | 1984-02-01 |
| NZ206907A (en) | 1987-03-31 |
| IL70757A0 (en) | 1984-04-30 |
| HU192390B (en) | 1987-06-29 |
| FI840268A0 (fi) | 1984-01-23 |
| ES529007A0 (es) | 1984-09-01 |
| EP0117171A1 (fr) | 1984-08-29 |
| DK31584A (da) | 1984-07-25 |
| CS53084A2 (en) | 1985-07-16 |
| AU560542B2 (en) | 1987-04-09 |
| SU1189345A3 (ru) | 1985-10-30 |
| US4524070A (en) | 1985-06-18 |
| ATE28077T1 (de) | 1987-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69333143T2 (de) | Substituierte chinuclidine als substanz p antagonisten | |
| DE69534975T2 (de) | Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern | |
| EP0222191B1 (de) | 4-Benzyl-1-(2H)-phthalazinon-Derivate | |
| EP1487834B1 (de) | Aza-bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor | |
| DD211351A5 (de) | Verfahren zur herstellung von neuen thieno-(3,2-c)pyridin-derivaten | |
| DE60103394T2 (de) | 4-(2-phenylthiazol-5-yl)1,4-diazabicyclo[3.2.2]nonanederivate, ihre herstellung und therapeutische verwendung | |
| DD201139A5 (de) | Verfahren zur herstellung von (-)-n-methyl-3-(2-methylphenoxy)-3-phenylpropylamin und seinen pharmazeutisch unbedenklichen salzen | |
| DE2504565A1 (de) | Neue derivate von 1h-imidazo(4,5-c) pyridin-7-carboxylsaeuren und -saeureestern | |
| DD202715A5 (de) | Verfahren zur herstellung von substituierten derivaten des pyridazin | |
| DE60103054T2 (de) | Phenyloxazol-1,4-diazabicyclo[3.2.2]nonanderivate, ihre herstellung und ihre therapeutische verwendung | |
| DD297819A5 (de) | Verfahren zur herstellung von 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidinderivaten | |
| DE69533194T2 (de) | PYRAZOLO(3,4-g)CHINOXALINE ALS PDGF-REZEPTOR PROTEIN TYROSIN-KINASE INHIBITOREN | |
| DE69828999T2 (de) | 1-(4-(1-(4-fluorophenyl)-1h-indol-3-yl)1-butyl)-spiro-(isobenzofuran-1(3h),4'-pperidin)-hydrohalogenide | |
| DE60003911T2 (de) | Heteroaryl-diazacycloalkane, ihre herstellung und verwendung | |
| DD215542A5 (de) | Verfahren zur herstellung von 4-cyano-pyridazinen | |
| DE60307102T2 (de) | 3-substituierte chinuclidine und ihre verwendung | |
| DD238793A5 (de) | Verfahren zur herstellung von amin-derivaten des pyrazins | |
| DE2802493A1 (de) | Neue imidazochinoline und deren salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE602004011805T2 (de) | Medizinische verwendung von zwitterion-verbindungen als modulatoren des cftr -kanals | |
| DE2633889C2 (de) | Neue Aminobenzocyclohepten-Derivate und deren Salze, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen | |
| DE1695111B1 (de) | Indolderivate | |
| EP1651645B1 (de) | N-biarylamide | |
| CH642966A5 (en) | 1-(2-Chlorophenyl)-4-[2-(1,3,4,5-tetrahydro-7,8-dimethoxy-2-benzox epin-1-yl)ethyl]piperazine and pharmacologically acceptable acid addition salts thereof | |
| EP0155903A1 (de) | Indolophenanthridine, ihre Herstellung und Verwendung | |
| DE69910574T2 (de) | Pyrazolo[1,5-a]triazine als crf antagonisten |